Compare PAVS & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAVS | GCTK |
|---|---|---|
| Founded | 2004 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2M | 3.0M |
| IPO Year | 2018 | 2011 |
| Metric | PAVS | GCTK |
|---|---|---|
| Price | $1.05 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 49.3K | ★ 5.9M |
| Earning Date | 07-31-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.02 | $0.09 |
| 52 Week High | $3.83 | $15.90 |
| Indicator | PAVS | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 36.39 |
| Support Level | $0.67 | N/A |
| Resistance Level | $1.20 | $1.02 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 3.33 | 9.60 |
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.